Showing Results for
- Academic Journals (12)
Search Results
- 12
Academic Journals
- 12
-
From:Future Oncology (Vol. 11, Issue 11) Peer-ReviewedAuthor(s): Maria Lina Tornesello aff1 , Luigi Buonaguro aff1 , Franco M Buonaguro [*] aff1 KEYWORDS biomarkers; cancer oncogenic pathogens; cell cycle; pathways Cancer arises from the progressive accumulation...
-
From:Future Oncology (Vol. 11, Issue 11) Peer-ReviewedAuthor(s): Robert Ballotti [*] KEYWORDS drug resistance; melanoma; plasticity; surface marker; tumorigenicity Melanoma facts Melanoma is one of the few cancers whose incidence has constantly been increasing...
-
From:Future Oncology (Vol. 11, Issue 11) Peer-ReviewedAuthor(s): Francesca Fenizia aff1 , Antonella De Luca aff2 , Raffaella Pasquale aff1 , Alessandra Sacco aff1 , Laura Forgione aff1 , Matilde Lambiase aff1 , Alessia Iannaccone aff1 , Nicoletta Chicchinelli aff2 , Renato...
-
From:Future Oncology (Vol. 11, Issue 11) Peer-ReviewedAuthor(s): María J Cejalvo aff1 , Javier de la Rubia [*] aff1 aff2 KEYWORDS front-line therapy; immunomodulatory drugs; lenalidomide; multiple myeloma Multiple myeloma (MM) is a malignant B-cell disorder...
-
From:Future Oncology (Vol. 11, Issue 11) Peer-ReviewedAuthor(s): Domenico Mattoscio aff1 , Susanna Chiocca [*] aff1 KEYWORDS biomarkers; cancer; SAE1/2; SUMO; SUMO ligases; SUMO proteases; Ubc9 Small Ubiquitin-related MOdifier (SUMO) is a post-translational...
-
From:Future Oncology (Vol. 11, Issue 11) Peer-ReviewedFollowing publication of the Review by Qian Huang & Xuenong Ouyang titled 'The role of miRNAs in bone metastasis and their significance in the detection of bone metastasis: a review of the published data', which...
-
From:Future Oncology (Vol. 11, Issue 11) Peer-ReviewedAuthor(s): Luigi Buonaguro [*] aff1 , Maria Tagliamonte aff1 , Annacarmen Petrizzo aff1 , Elvira Damiano aff1 , Maria Lina Tornesello aff1 , Franco M Buonaguro aff1 KEYWORDS cancer-associated fibroblasts; hepatic...
-
From:Future Oncology (Vol. 11, Issue 11) Peer-ReviewedAuthor(s): Marc De Braekeleer [*] aff1 aff2 aff3 , Marie-Josée Le Bris aff3 , Etienne De Braekeleer aff4 aff5 , Audrey Basinko aff2 aff3 , Frédéric Morel aff1 aff2 aff3 , Nathalie Douet-Guilbert aff1 aff2 aff3...
-
From:Future Oncology (Vol. 11, Issue 11) Peer-ReviewedAuthor(s): Franco M Buonaguro [*] aff1 , Maria Lina Tornesello aff1 , Luigi Buonaguro aff1 KEYWORDS cancer biomarkers; cancer determinants; cancer pathways; HCC; lung cancer; melanoma; SUMO pathway Cancer...
-
From:Future Oncology (Vol. 11, Issue 11) Peer-ReviewedAuthor(s): Jose Muñoz-Langa [*] aff1 , Javier De Castro aff2 , Pere Gascó aff3 , Alfredo Sanchez aff4 , Emilio Esteban aff5 , Jose Manuel Gasent aff6 , Isidoro Barneto aff7 , Joaquin Montalar aff8 , Angel Artal aff9 ,...
-
From:Future Oncology (Vol. 11, Issue 11) Peer-ReviewedAuthor(s): Zebo Huang aff1 , Yinxia Wu aff2 , Xin Zhou aff1 , Jiaqi Qian aff1 , Wei Zhu [*] aff1 , Yongqian Shu aff1 , Ping Liu aff1 KEYWORDS clinical trials; mTOR inhibitor; solid tumor Increasingly, numerous...
-
From:Future Oncology (Vol. 11, Issue 11) Peer-ReviewedABSTRACT The prognosis of patients with relapsed/refractory peripheral T-cell lymphoma (PTCL) remains poor and current treatments are typically of limited benefit. Histone deacetylase (HDAC) inhibitors have proven...